Semnur Pharmaceuticals (SMNR) Stock Price, News & Analysis
Company Description
Semnur Pharmaceuticals (OTC Link: SMNR) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $195.7M.
For FY2025, Semnur Pharmaceuticals and diluted earnings per share of $-0.78.
This page collects what Stock Titan holds for SMNR, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Semnur Pharmaceuticals (SMNR) stock last closed at $0.8500. At a market capitalization of $195.7M, SMNR is classified as a micro-cap stock with approximately 230.2M shares outstanding.
Latest News
Semnur Pharmaceuticals has 1 recent news article. Of the recent coverage, 1 article coincided with positive price movement and 0 with negative movement. View all SMNR news →
SEC Filings
Semnur Pharmaceuticals has filed 5 recent SEC filings, including 2 Form 424B3, 1 Form 4, 1 Form 8-K, 1 Form SCHEDULE 13D/A. The most recent filing was submitted on July 7, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all SMNR SEC filings →
Financial Highlights
Diluted earnings per share stood at $-0.78. The company generated -$5.9M in operating cash flow. With a current ratio of 0.06, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Semnur Pharmaceuticals (SMNR) currently stands at 107.2 thousand shares, down 12.1% from the previous reporting period, representing 0.3% of the float. Since September 2025, short interest has increased by 6492.4%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Semnur Pharmaceuticals (SMNR) currently stands at 1.4 days, up 41% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 85.8% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
SMNR Company Profile & Sector Positioning
Semnur Pharmaceuticals (SMNR) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.